Patterson Companies, Inc. (PDCO)
NASDAQ: PDCO · Real-Time Price · USD
31.14
0.00 (0.00%)
Mar 14, 2025, 4:00 PM EDT - Market closed
Patterson Companies Revenue
Patterson Companies had revenue of $1.57B in the quarter ending January 25, 2025, a decrease of -2.70%. This brings the company's revenue in the last twelve months to $6.51B, down -0.85% year-over-year. In the fiscal year ending April 27, 2024, Patterson Companies had annual revenue of $6.57B with 1.50% growth.
Revenue (ttm)
$6.51B
Revenue Growth
-0.85%
P/S Ratio
0.42
Revenue / Employee
$856,735
Employees
7,600
Market Cap
2.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 27, 2024 | 6.57B | 96.80M | 1.50% |
| Apr 29, 2023 | 6.47B | -27.93M | -0.43% |
| Apr 30, 2022 | 6.50B | 587.34M | 9.93% |
| Apr 24, 2021 | 5.91B | 422.06M | 7.69% |
| Apr 25, 2020 | 5.49B | -84.51M | -1.52% |
| Apr 27, 2019 | Pro | Pro | Pro |
| Apr 28, 2018 | Pro | Pro | Pro |
| Apr 29, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
| Apr 25, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PDCO News
- 16 days ago - Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results - Business Wire
- 7 weeks ago - Patterson Companies Announces Expiration of “Go-Shop” Period - Business Wire
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders - GlobeNewsWire
- 3 months ago - What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players? - Benzinga
- 3 months ago - Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade) - Seeking Alpha
- 3 months ago - Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal - Benzinga
- 3 months ago - Patterson Cos. to Be Acquired by Patient Square Capital for $4.1 Billion - Barrons
- 3 months ago - Patterson Companies Announces Definitive Agreement to Be Acquired by Patient Square Capital for $31.35 Per Share in Cash - Business Wire